When should a new test become the current reference standard?

Annals of Internal Medicine

Volumn 149, Issue 11, 2008, Pages 816-821

  Glasziou, Paul ^a   Irwig, Les ^b   Deeks, Jonathan J ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; CLINICAL PRACTICE; DIAGNOSTIC TEST; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; GOLD STANDARD; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN TEST; TREATMENT RESPONSE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 57349182655     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-149-11-200812020-00009     Document Type: Review

References (23)

1. Whiting P, Harbord R, Main C, Deeks JJ, Filippini G, Egger M, et al. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ. 2006;332:875-84. [PMID: 16565096]
2. Katz IA, Irwig L, Vinen JD, March L, Wyndham LE, Luu T, et al. Biochemical markers of acute myocardial infarction: strategies for improving their clinical usefulness. Ann Clin Biochem. 1998;35 (Pt 3):393-9. [PMID: 9635105]
3. Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA. 2000;283:2680-5. [PMID: 10819951]
4. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625. [PMID: 15774989]
5. Maehara T. Neuroimaging of epilepsy. Neuropathology. 2007;27:585-93. [PMID: 18021381]
6. Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ. 2006;332:1089-92. [PMID: 16675820]
7. Rutjes AW, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PM. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess. 2007;11:iii, ix-51. [PMID: 18021577]
8. Hadgu A. The discrepancy in discrepant analysis. Lancet. 1996;348:592-3. [PMID: 8774575]
9. Hadgu A. Discrepant analysis: a biased and an unscientific method for estimating test sensitivity and specificity. J Clin Epidemiol. 1999;52:1231-7. [PMID: 10580787]
10. McAdam AJ. Discrepant analysis: how can we test a test? J Clin Microbiol. 2000;38:2027-9. [PMID: 10834948]
11. Irwig LM, Groeneveld HT, Pretorius JP, Hnizdo E. Relative observer accuracy for dichotomized variables. J Chronic Dis. 1985;38:899-906. [PMID: 4055978]
12. Sanders DS, Carter MJ, Hurlstone DP, Pearce A, Ward AM, McAlindon ME, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 2001;358:1504-8. [PMID: 11705563]
13. Catassi C, Fabiani E. The spectrum of coeliac disease in children. Baillieres Clin Gastroenterol. 1997;11:485-507. [PMID: 9448912]
14. Irwig L, Houssami N, Armstrong B, Glasziou P. Evaluating new screening tests for breast cancer [Editorial]. BMJ. 2006;332:678-9. [PMID: 16565097]
15. Hoenig MR, Doust JA, Aroney CN, Scott IA. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev. 2006;3:CD004815. [PMID: 16856061]
16. O'Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, et al. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300:71-80. [PMID: 18594042]
17. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ. 2007;334:349-51. [PMID: 17303884]
18. Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet. 2000;356:1844-7. [PMID: 11117930]
19. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061-6. [PMID: 10493205]
20. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168-73. [PMID: 12686038]
21. Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, Aslan Y, et al. Prognostic value of a T-cell- based, interferon-γ biomarker in children with tuberculosis contact. Ann Intern Med. 2008;149:777-786.
22. Alonzo TA, Pepe MS. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat Med. 1999;18:2987-3003. [PMID: 10544302]
23. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med. 2006;144:850-5. [PMID: 16754927]